Larsimont D - Search Results

1

Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.

Recloux P, Dodion PF, Andry G, Chantrain G, Dor P, Buyse M, Van Houtte P, Lemort M, Haesendonck P, Larsimont D. Recloux P, et al. Among authors: larsimont d. Eur J Surg Oncol. 1989 Dec;15(6):568-74. Eur J Surg Oncol. 1989. PMID: 2480922

2

Human medullary thyroid carcinoma: cell cultures and xenotransplants in nude mice. Immunocytochemistry and calcitonin secretion.

Andry G, Lothaire P, Vico P, Dumont P, Libert A, Degeyter M, Larsimont D, Saigo PE, Body JJ, Atassi G, et al. Andry G, et al. Among authors: larsimont d. Eur J Surg Oncol. 1989 Dec;15(6):556-63. Eur J Surg Oncol. 1989. PMID: 2689238

3

Tumor type and vascularity: important variables in infusional brachytherapy with colloidal 32P.

Nguyen H, Ghanem G, Morandini R, Verbist A, Larsimont D, Fallais C, Frühling J, Van Houtte P. Nguyen H, et al. Among authors: larsimont d. Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):481-7. doi: 10.1016/s0360-3016(97)00294-0. Int J Radiat Oncol Biol Phys. 1997. PMID: 9308954

4

[Death from myocardial metastasis of thyroid cancers (insular, papillary with undifferentiated foyers)].

Larsimont D, Renard N, Andry G. Larsimont D, et al. Ann Chir. 1998;52(5):465-8. Ann Chir. 1998. PMID: 9752489 French.

5

Late onset of tonsillar metastasis from breast cancer.

Tueche SG, Nguyen H, Larsimont D, Andry G. Tueche SG, et al. Among authors: larsimont d. Eur J Surg Oncol. 1999 Aug;25(4):439-40. doi: 10.1053/ejso.1999.0672. Eur J Surg Oncol. 1999. PMID: 10419718

6

Unilateral thyroid lobectomy for differentiated thyroid carcinoma: long-term results.

Andry G, Paesmans M, Delmelle M, Lothaire P, Larsimont D. Andry G, et al. Among authors: larsimont d. Acta Otorhinolaryngol Belg. 1999;53(3):173. Acta Otorhinolaryngol Belg. 1999. PMID: 10635386 No abstract available.

7

A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer.

Di Leo A, Crown J, Nogaret JM, Duffy K, Bartholomeus S, Dolci S, Rowan S, O'Higgins N, Paesmans M, Larsimont D, Riva A, Piccart MJ. Di Leo A, et al. Among authors: larsimont d. Ann Oncol. 2000 Feb;11(2):169-75. doi: 10.1023/a:1008345432342. Ann Oncol. 2000. PMID: 10761751 Free article. Clinical Trial.

8

[Fibrosarcomatous variant of dermatofibrosarcoma protuberans: clinicopathologic analysis of 4 cases].

Diedhiou A, Larsimont D, Vandeweyer E, Andry G, De Saint-Aubain Somerhausen N. Diedhiou A, et al. Among authors: larsimont d. Ann Pathol. 2001 Apr;21(2):164-7. Ann Pathol. 2001. PMID: 11373589 French.

9

The predictive value of HER2 in breast cancer.

Piccart M, Lohrisch C, Di Leo A, Larsimont D. Piccart M, et al. Among authors: larsimont d. Oncology. 2001;61 Suppl 2:73-82. doi: 10.1159/000055405. Oncology. 2001. PMID: 11694791 Review.

10

Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients.

Bernard-Marty C, Mano M, Paesmans M, Accettura C, Munoz-Bermeo R, Richard T, Kleiber K, Cardoso F, Lobelle JP, Larsimont D, Piccart MJ, Di Leo A. Bernard-Marty C, et al. Among authors: larsimont d. Ann Oncol. 2003 May;14(5):693-8. doi: 10.1093/annonc/mdg204. Ann Oncol. 2003. PMID: 12702521 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters